• Issue

    European Journal of Heart Failure: Volume 13, Issue 6

    579-689
    June 2011
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Review

Free Access

Tumour biomarkers in heart failure: is there a role for CA-125?

Mehmet Birhan Yilmaz,  Maria Nikolaou,  Alain Cohen Solal, 
  • Pages: 579-583
  • First Published: 18 February 2014
Free Access

Systematic review of pregnancy in women with inherited cardiomyopathies

Sébastien P.J. Krul,  Jasper J. van der Smagt,  Maarten P. van den Berg,  Krystyna M. Sollie,  Petronella G. Pieper,  Karin Y. van Spaendonck-Zwarts, 
  • Pages: 584-594
  • First Published: 18 February 2014

Editorials

Free Access

Vitamin D status: to be considered in heart failure patients!

Stefan Pilz,  Andreas Tomaschitz, 
  • Pages: 595-596
  • First Published: 18 February 2014
Free Access

Heart failure and the brain, a wake-up call

Gert-Jan Luijckx,  Maarteen P. van den Berg, 
  • Pages: 597-598
  • First Published: 18 February 2014
Free Access

Biventricular pacing in pacemaker dependency: one size does not fit all

Alexander H. Maass,  Cheuk-Man Yu, 
  • Pages: 599-601
  • First Published: 18 February 2014

Experimental

Free Access

The toll-like receptor 4-antagonist eritoran reduces murine cardiac hypertrophy

Heidi Ehrentraut,  Carolyn Weber,  Stefan Ehrentraut,  Markus Schwederski,  Olaf Boehm,  Pascal Knuefermann,  Rainer Meyer,  Georg Baumgarten, 
  • Pages: 602-610
  • First Published: 18 February 2014

Histopathology

Free Access

Expression of functional T-cell markers and T-cell receptor Vbeta repertoire in endomyocardial biopsies from patients presenting with acute myocarditis and dilated cardiomyopathy

Michel Noutsias,  Maria Rohde,  Katrin Göldner,  Andrea Block,  Katja Blunert,  Lara Hemaidan,  Michael Hummel,  Jan-Henrik Blohm,  Dirk Lassner,  Uwe Kühl,  Heinz-Peter Schultheiss,  Hans-Dieter Volk,  Katja Kotsch, 
  • Pages: 611-618
  • First Published: 18 February 2014

Prognosis

Free Access

Vitamin D status and outcomes in heart failure patients

Licette C.Y. Liu,  Adriaan A. Voors,  Dirk J. van Veldhuisen,  Eveline van der Veer,  Anne M. Belonje,  Mariusz K. Szymanski,  Herman H.W. Silljé,  Wiek H. van Gilst,  Tiny Jaarsma,  Rudolf A. de Boer, 
  • Pages: 619-625
  • First Published: 18 February 2014
Free Access

Parathyroid hormone and vitamin D—markers for cardiovascular and all cause mortality in heart failure

Louise Lind Schierbeck,  Torben Slott Jensen,  Ulrich Bang,  Gorm Jensen,  Lars Køber,  Jens-Erik Beck Jensen, 
  • Pages: 626-632
  • First Published: 18 February 2014

Device Therapy

Free Access

Preventing ventricular dysfunction in pacemaker patients without advanced heart failure: results from a multicentre international randomized trial (PREVENT-HF)

Martin Stockburger,  Juan José Gómez-Doblas,  Gervasio Lamas,  Javier Alzueta,  Ignacio Fernández-Lozano,  Erik Cobo,  Uwe Wiegand,  Joaquín Fernández de la Concha,  Xavier Navarro,  Francisco Navarro-López,  Eduardo de Teresa, 
  • Pages: 633-641
  • First Published: 18 February 2014

Exercise Physiology

Free Access

Exercise training reduces serum capacity to induce endothelial cell death in patients with chronic heart failure

Caterina Mammi,  Andrea la Sala,  Maurizio Volterrani,  Lucia Gatta,  Antonella Antelmi,  Alessandra Feraco,  Giuseppe Caminiti,  Giuseppe Marazzi,  Cristiana Vitale,  Massimiliano Caprio,  Giuseppe Massimo Claudio Rosano, 
  • Pages: 642-650
  • First Published: 18 February 2014

Comorbidities

Free Access

Global and regional putamen volume loss in patients with heart failure

Rajesh Kumar,  Haidang D. Nguyen,  Jennifer A. Ogren,  Paul M. Macey,  Paul M. Thompson,  Gregg C. Fonarow,  Michele A. Hamilton,  Ronald M. Harper,  Mary A. Woo, 
  • Pages: 651-655
  • First Published: 18 February 2014
Free Access

Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study

Stephan von Haehling,  Dirk J. van Veldhuisen,  Michael Roughton,  Daphne Babalis,  Rudolf A. de Boer,  Andrew J.S. Coats,  Luis Manzano,  Marcus Flather,  Stefan D. Anker, 
  • Pages: 656-663
  • First Published: 18 February 2014
Free Access

Competing risks of heart failure with preserved ejection fraction in diabetic patients

Yasuharu Takeda,  Yasushi Sakata,  Toshiaki Mano,  Tomohito Ohtani,  Daisuke Kamimura,  Shunsuke Tamaki,  Yosuke Omori,  Yasumasa Tsukamoto,  Yoshihiro Aizawa,  Issei Komuro,  Kazuhiro Yamamoto, 
  • Pages: 664-669
  • First Published: 18 February 2014

Treatment

Open Access

Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial

Hans-Dirk Düngen,  Svetlana Apostolović,  Simone Inkrot,  Elvis Tahirović,  Agnieszka Töpper,  Felix Mehrhof,  Christiane Prettin,  Biljana Putniković,  Aleksandar N. Nešković,  Mirjana Krotin,  Dejan Sakač,  Mitja Lainščak,  Frank Edelmann,  Rolf Wachter,  Thomas Rau,  Thomas Eschenhagen,  Wolfram Doehner,  Stefan D. Anker,  Finn Waagstein,  Christoph Herrmann-Lingen,  Goetz Gelbrich,  Rainer Dietz,  on behalf of the CIBIS-ELD investigators and Project Multicentre Trials in the Competence Network Heart Failure , 
  • Pages: 670-680
  • First Published: 18 February 2014

Pharmacoeconomics

Free Access

Cost-effectiveness of highly purified omega-3 polyunsaturated fatty acid ethyl esters in the treatment of chronic heart failure: results of Markov modelling in a UK setting

Martin R. Cowie,  Sandrine Cure,  Florence Bianic,  Alistair McGuire,  Gordon Goodall,  Luigi Tavazzi, 
  • Pages: 681-689
  • First Published: 18 February 2014